Please login to the form below
ABPI
This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.
Industry pleads for compromise after Brexit defeat
The Association of the British Pharmaceutical Industry (ABPI) chief executive Mike Thompson said that no-deal would be “extremely challenging” and raises the risk that access to medicines may be disrupted
Latest news
-
Blackwood returns as new life sciences minister
Indeed, while careful to avoid taking too political a stance, the pharma industry association the ABPI has made it very clear that a no deal Brexit must be avoided at all
-
NHS Long-term Plan welcomed – but warnings on staff and overpromising
ABPI chief executive Mike Thompson. Mike Thompson, chief executive of the ABPI, nevertheless welcomed the announcement, saying:. ... The ABPI welcomes the NHS Long Term Plan’s ambition to save lives and improve patient outcomes through investing in
-
Post-Brexit immigration policy has a critical missing piece
ABPI welcomes focus on skills, but UK must respond fast to skills gaps. ... In general terms, a shift to a skills-based migration policy is a good thing, according to the Association of the British Pharmaceutical Industry (ABPI), which said it
-
Business warning as talk of Brexit ‘No deal’ grows
Asked for its views, a spokesperson for the UK pharma industry association the ABPI said it reiterated its message from 7 December, when the health secretary Matt Hancock issued medicines-specific ... This update was nearly two weeks ago, when the ABPI
-
NICE appraisal fees to be introduced despite opposition
The ABPI had suggested an alternative solution to the fees question, in which rebates from this scheme (or the parallel statutory scheme) would be paid annually by the industry as a ... The ABPI's Dr Richard Torbett. Dr Richard Torbett, Director of
More from news
Approximately 87 fully matching, plus 473 partially matching documents found.
Latest Intelligence
-
The UK’s new five-year pricing agreement
Industry leaders who have voiced their support for the deal include Novartis’ UK country president Haseeb Ahmad and EMIG’s chairman Leslie Galloway, who says the ABPI’s negotiating team had ... NHS England, with input from NICE and ABPI, committed
-
Brexit: can pharma 'take back control' of the narrative?
For this reason, as the clock ticks down, the sector urgently needs greater clarification across the five broad areas that have been identified by the ABPI and BIA: access to ... Nonetheless despite this, the ABPI has long-highlighted the need to bridge
-
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK managing director and newly appointed ABPI President talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe. " />.
-
Joint working that works
The ABPI and Department of Health defined how companies and the NHS can pool skills, experience and resources to plan and deliver patient-centred projects. ... Our experts reflected that the healthcare landscape has evolved since Moving Beyond
-
The case for a second Brexit referendum: “We need the informed consent of the people”
There is no doubt that the amendment was seen in the UK pharma industry as a huge vote of support – even if trade organisation the ABPI is very careful about speaking
More from intelligence
Approximately 7 fully matching, plus 41 partially matching documents found.
Latest appointments
-
Neurocentrx appoints two members to the board
His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
-
Professor Carole Longson moves from NICE to the ABPI
Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our
-
HCA appoints Mike Dixon as its new CEO
Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical
-
AZ's Lisa Anson elected president of ABPI
year. Anson joined the ABPI board in 2012 and has since overseen a number of schemes for the association, including the implementation of the Pharmaceutical Pricing Regulation Scheme. ... Speaking on behalf of the board and all staff at the ABPI, we very
-
ABPI appoints Mike Thompson as chief executive
He replaces acting chief executive officer Alison Clough. The Association of the British Pharmaceutical Industry (ABPI) has named Mike Thompson as its new chief executive, who will replace Alison Clough on ... and his strategic capabilities will be huge
More from appointments
Approximately 21 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Pharma exhibition stand design: size doesn’t have to matter
Of course, you’ll also need to be aware of any company restrictions, pharma industry regulations (ABPI), and local country regulations.
-
Making a Difference - The Future of Pharma
On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy, supports almost 500, 000 jobs in the UK alone, and donated 1.4 BN treatments to the
-
OUTiCO growth in multi-channel creates more job openings
To succeed in this role you’ll need relevant experience in a key account management role, or similar, and be ABPI qualified.
-
Unique forum will unite NHS and industry to drive innovation
Representatives from NICE, MHRA and ABPI will also be among those involved in the wide-ranging debates which will help guests to understand how to develop relationships with and deliver innovation
-
Social Media and Health: the Cure or the Disease?
There is little guidance on social media from regulatory bodies like the FDA, EMA and ABPI, and some companies have unwittingly breached codes due to posts by themselves or their customers. . .
More from PMHub
Approximately 2 fully matching, plus 21 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Senior Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Global Business Development Director – Health Education
-
excellent commission
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- AZ’s Sean Bohen to exit after business overhaul; report
- FDA moves into crisis mode as shutdown drags on
- Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Quick links
Infographics
